Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy
Fabry disease (FD) is a genetic lysosomal storage disease with frequent cardiovascular involvement, whose presence is a major determinant of adverse clinical outcomes. As a potentially treatable cause of left ventricular hypertrophy (LVH) and heart failure with preserved ejection fraction, the early...
Main Authors: | Kamil Stankowski, Stefano Figliozzi, Vincenzo Battaglia, Federica Catapano, Marco Francone, Lorenzo Monti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-11-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/12/22/7061 |
Similar Items
-
Solving the Riddle of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: The Added Role of Cardiac Magnetic Resonance
by: Kamil Stankowski, et al.
Published: (2023-05-01) -
Left ventricular myocardial strain and electrocardiographic changes in children with hypertrophic cardiomyopathy
by: N. Yu. Chernykh, et al.
Published: (2021-08-01) -
Unraveling an Unusual Phenocopy of Hypertrophic Cardiomyopathy: MELAS Syndrome
by: Anna B. Reid, et al.
Published: (2021-02-01) -
Sex Differences in Anderson–Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women
by: Denise Cristiana Faro, et al.
Published: (2023-09-01) -
Modeling of factors affecting late gadolinium enhancement kinetics in MRI of cardiac amyloid
by: Leon Axel
Published: (2023-08-01)